Literature DB >> 18378566

Individual physician practice variation in hematopoietic cell transplantation.

Stephanie J Lee1, Steven Joffe, Andrew S Artz, Richard E Champlin, Stella M Davies, Madan Jagasia, Nancy A Kernan, Fausto R Loberiza, Robert J Soiffer, Mary Eapen.   

Abstract

PURPOSE: Previous studies have evaluated practice variation in hematopoietic cell transplantation (HCT) among transplant centers and countries. There are no studies investigating individual physician practice variation in HCT.
METHODS: An international Internet-based survey of transplant physicians collected data on medical decisions made by adult and pediatric HCT physicians. Multivariable analyses identified practitioner and transplant center characteristics predictive of medical decision making.
RESULTS: Analysis of 526 assessable respondents showed a wide variation in management approaches to specific clinical scenarios. Pediatric and adult transplant physicians differed significantly in their management strategies for chronic myeloid leukemia, acute and chronic graft-versus-host disease, and choice of graft source for patients with aplastic anemia. Among adult transplant physicians, there was little agreement on the patient factors favoring reduced intensity conditioning or myeloablative conditioning.
CONCLUSION: These results emphasize the heterogeneity of worldwide transplant practices. Local preferences or biases likely result in similar patients being offered different transplant and treatment procedures. The degree of practice variation also highlights the need for clinical trials to clarify areas of controversy. Where clinical trials are not feasible, data from observational studies may be the best available evidence to guide practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378566     DOI: 10.1200/JCO.2007.15.0169

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  20 in total

1.  Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States.

Authors:  Julian A Abrams; Robert C Kapel; Guy M Lindberg; Mohammad H Saboorian; Robert M Genta; Alfred I Neugut; Charles J Lightdale
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-13       Impact factor: 11.382

2.  Guest editorial: Role of monoclonal antibodies for the prevention and treatment of graft-versus-host disease.

Authors:  Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2011-05-11       Impact factor: 2.490

Review 3.  Persistent Disparities in Adult Hematopoietic Cell Transplantation.

Authors:  David G Crockett; Fausto R Loberiza
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

Review 4.  Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation.

Authors:  Navneet S Majhail
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

5.  Physician styles of patient management as a potential source of disparities: cluster analysis from a factorial experiment.

Authors:  Karen E Lutfey; Eric Gerstenberger; John B McKinlay
Journal:  Health Serv Res       Date:  2012-10-22       Impact factor: 3.402

6.  Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians.

Authors:  William A Wood; Margaret K McGinn; Doug Wilson; Allison M Deal; Nandita Khera; Thomas C Shea; Steven M Devine; Frederick R Appelbaum; Mary M Horowitz; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2016-07-29       Impact factor: 5.742

7.  Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Stephanie J Lee; Gwen Quinn; Heather Jim; Jongphil Kim; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-11       Impact factor: 5.742

8.  Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Barry E Storer; Stephanie J Lee; Paul A Carpenter; Brenda M Sandmaier; Mary E D Flowers; Paul J Martin
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

9.  Costs of pediatric allogeneic hematopoietic-cell transplantation.

Authors:  Navneet S Majhail; Jaya M Mothukuri; Margaret L Macmillan; Michael R Verneris; Paul J Orchard; John E Wagner; Daniel J Weisdorf
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

Review 10.  Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.

Authors:  Paul J Martin; Carlos R Bachier; Hans-Georg Klingemann; Philip L McCarthy; Paul Szabolcs; Joseph P Uberti; Michael W Schuster; Daniel Weisdorf; Nelson J Chao; Partow Kebriaei; Elizabeth J Shpall; Margaret L Macmillan; Robert J Soiffer
Journal:  Biol Blood Marrow Transplant       Date:  2009-05-13       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.